The interactions of dendritic cells with antigen-specitic, regulatory T cells that suppress autoimmunity

被引:99
作者
Tarbell, KV
Yamazaki, S
Steinman, RM
机构
[1] Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10021 USA
[2] Rockefeller Univ, Chris Browne Ctr Immunol & Immune Dis, New York, NY 10021 USA
关键词
dendritic cells; regulatory T cells; autoimmunity; NOD mice; tolerance;
D O I
10.1016/j.smim.2006.01.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dendritic cells (DCs) are important for several aspects of the development and function of CD4+ CD25+ regulatory T cells (Tregs), which are critical for maintaining peripheral tolerance and preventing autoimmunity. In cultures from human thymus, dendritic cells (DCs) conditioned with thymic stromal lymphopoietin (TSLP) mediate the production of Tregs from CD4+ CD25- thymocytes. In cultures from mouse lymphoid organs, CD86-rich DCs induce the proliferation and improved suppressive function of antigen-specific Tregs. DC-expanded, antigen-specific Tregs show greatly enhanced efficacy relative to polyclonal populations in blocking experimental autoimmunity. In several animal models including NOD diabetes, Tregs directed to one autoantigen are able to block autoimmunity induced by multiple antigens from the target organ. Distinct states of DC differentiation or maturation are likely to be important for the emerging roles of DCs in the biology of Tregs, particularly the control of autoimmunity in an antigen-dependent manner. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:93 / 102
页数:10
相关论文
共 108 条
[51]  
Mahnke K, 2003, BLOOD, V101, P4862, DOI 10.1182/blood-2002-10-3229
[52]   CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice:: implications for the nonredundant function of IL-2 [J].
Malek, TR ;
Yu, AX ;
Vincek, V ;
Scibelli, P ;
Kong, L .
IMMUNITY, 2002, 17 (02) :167-178
[53]   Tolerance, not immunity, crucially depends on IL-2 [J].
Malek, TR ;
Bayer, AL .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (09) :665-674
[54]   Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice [J].
Masteller, EL ;
Warner, MR ;
Tang, QZ ;
Tarbell, KV ;
McDevitt, H ;
Bluestone, JA .
JOURNAL OF IMMUNOLOGY, 2005, 175 (05) :3053-3059
[55]   Early social mixing and childhood Type 1 diabetes mellitus: a case-control study in Yorkshire, UK [J].
McKinney, PA ;
Okasha, M ;
Parslow, RC ;
Law, GR ;
Gurney, KA ;
Williams, R ;
Bodansky, HJ .
DIABETIC MEDICINE, 2000, 17 (03) :236-242
[56]   Cutting edge:: Cure of colitis by CD4+ CD25+ regulatory T cells [J].
Mottet, C ;
Uhlig, HH ;
Powrie, F .
JOURNAL OF IMMUNOLOGY, 2003, 170 (08) :3939-3943
[57]   CD4+ CD25+ regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo [J].
Oldenhove, G ;
de Heusch, M ;
Urbain-Vansanten, G ;
Urbain, J ;
Maliszewski, C ;
Leo, O ;
Moser, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (02) :259-266
[58]   Unmasking immunosurveillance against a syngeneic colon cancer by elimination of CD4+ NKT regulatory cells and IL-13 [J].
Park, JM ;
Terabe, M ;
van den Broeke, LT ;
Donaldson, DD ;
Berzofsky, JA .
INTERNATIONAL JOURNAL OF CANCER, 2005, 114 (01) :80-87
[59]   Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells [J].
Pasare, C ;
Medzhitov, R .
SCIENCE, 2003, 299 (5609) :1033-1036
[60]   Single cell analysis shows decreasing FoxP3 and TGFβ1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes [J].
Pop, SM ;
Wong, CP ;
Culton, DA ;
Clarke, SH ;
Tisch, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (08) :1333-1346